Vaxart, Inc. (NASDAQ:VXRT) Stock Catapults 34% Though Its Price And Business Still Lag The Industry
Vaxart, Inc. (NASDAQ:VXRT) shareholders would be excited to see that the share price has had a great month, posting a 34% gain and recovering from prior weakness. Not all shareholders will be feeling jubilant, since the share price is still down a very disappointing 13% in the last twelve months.
In spite of the firm bounce in price, Vaxart may still look like a strong buying opportunity at present with its price-to-sales (or “P/S”) ratio of 3x, considering almost half of all companies in the Biotechs industry in the United States have P/S ratios greater than 8.2x and even P/S higher than 53x aren’t out of the ordinary. Nonetheless, we’d need to dig a little deeper to determine if there is a rational basis for the highly…
